Global Biosimilars Market to Hit Sales of $68.95 Billion by 2028 | Biocon, Sanofi, and Ely Lilly and Company Hold Over 90% of Insulin Biosimilars Market Westford, USA, Aug. 03, 2022 (GLOBE NEWSWIRE) -- According to a study by SkyQuest Technology, biosimilars market generated $12.24 billion in global sales in 2020. This is an 85% increase from the...